Cargando…

P12. Combination of radiotherapy and chemotherapy with dendritic cell immunotherapy in glioblastoma patients induces NK and NKT cell responses

Detalles Bibliográficos
Autores principales:	Pellegatta, S, Eoli, M, Bruzzone, MG, Cuzzubbo, S, Anghileri, E, Antozzi, C, Frigerio, S, Pollo, B, Parati, EA, Finocchiaro, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072109/ http://dx.doi.org/10.1186/2051-1426-2-S2-P3

Ejemplares similares

Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8(+) T cell activation in the presence of adjuvant temozolomide
por: Pellegatta, Serena, et al.
Publicado: (2018)

The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysates
por: Pellegatta, Serena, et al.
Publicado: (2013)

ABCC3 Expressed by CD56(dim) CD16(+) NK Cells Predicts Response in Glioblastoma Patients Treated with Combined Chemotherapy and Dendritic Cell Immunotherapy
por: Pellegatta, Serena, et al.
Publicado: (2019)

Expansion of effector and memory T cells is associated with increased survival in recurrent glioblastomas treated with dendritic cell immunotherapy
por: Eoli, Marica, et al.
Publicado: (2019)

Advanced MRI Assessment during Dendritic Cell Immunotherapy Added to Standard Treatment against Glioblastoma
por: Cuccarini, Valeria, et al.
Publicado: (2019)

An Optimized Method for Manufacturing a Clinical Scale Dendritic Cell-Based Vaccine for the Treatment of Glioblastoma
por: Nava, Sara, et al.
Publicado: (2012)

PGE(2) Is Crucial for the Generation of FAST Whole- Tumor-Antigens Loaded Dendritic Cells Suitable for Immunotherapy in Glioblastoma
por: Nava, Sara, et al.
Publicado: (2020)

Prognostic Value of CD109+ Circulating Endothelial Cells in Recurrent Glioblastomas Treated with Bevacizumab and Irinotecan
por: Cuppini, Lucia, et al.
Publicado: (2013)

Deciphering the Labyrinthine System of the Immune Microenvironment in Recurrent Glioblastoma: Recent Original Advances and Lessons from Clinical Immunotherapeutic Approaches
por: Anghileri, Elena, et al.
Publicado: (2021)

Advances in NKT cell Immunotherapy for Glioblastoma
por: Pyaram, Kalyani, et al.
Publicado: (2018)

Parametric Response Maps of Perfusion MRI May Identify Recurrent Glioblastomas Responsive to Bevacizumab and Irinotecan
por: Aquino, Domenico, et al.
Publicado: (2014)

Frequency of NFKBIA deletions is low in glioblastomas and skewed in glioblastoma neurospheres
por: Patanè, Monica, et al.
Publicado: (2013)

Enhancing Neuroblastoma Immunotherapies by Engaging iNKT and NK Cells
por: McNerney, Kevin O., et al.
Publicado: (2020)

Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer
por: Smyth, Mark J., et al.
Publicado: (2005)

Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells
por: Smyth, Mark J., et al.
Publicado: (2000)

NK Cell-Based Glioblastoma Immunotherapy
por: Golán, Irene, et al.
Publicado: (2018)

The Role of NKT Cells in Glioblastoma
por: Brettschneider, Emily E. S., et al.
Publicado: (2021)

NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma
por: Speranza, Maria Carmela, et al.
Publicado: (2012)

Impaired NK and NKT cells immunobiology in rheumatoid arthritis
por: Aggarwal, Ashish, et al.
Publicado: (2012)

NK and NKT-Like Cells in Patients with Recurrent Furunculosis
por: Nowicka, Danuta, et al.
Publicado: (2017)

Discovery of NKT cells and development of NKT cell-targeted anti-tumor immunotherapy
por: TANIGUCHI, Masaru, et al.
Publicado: (2015)

Challenges and Prospects for Designer T and NK Cells in Glioblastoma Immunotherapy
por: Arnesen, Victoria Smith, et al.
Publicado: (2021)

Editorial: NKT Cells in Cancer Immunotherapy
por: Webb, Tonya J., et al.
Publicado: (2020)

Recent Development in NKT-Based Immunotherapy of Glioblastoma: From Bench to Bedside
por: Li, Yutao, et al.
Publicado: (2022)

Revisiting the Immunological Aspects of Temozolomide Considering the Genetic Landscape and the Immune Microenvironment Composition of Glioblastoma
por: Di Ianni, Natalia, et al.
Publicado: (2021)

The Important Role of Dendritic Cell (DC) in iNKT-Mediated Modulation of NK Cell Function in Chlamydia pneumoniae Lung Infection
por: Zhao, Lei, et al.
Publicado: (2019)

NKG2C+ NK Cells for Immunotherapy of Glioblastoma Multiforme
por: Murad, Shafiq, et al.
Publicado: (2022)

Erratum: Editorial: NKT Cells in Cancer Immunotherapy
Publicado: (2020)

Dendritic Cells and Cancer Immunotherapy: The Adjuvant Effect
por: Nava, Sara, et al.
Publicado: (2021)

Cytotoxic lymphocytes in COPD airways: increased NK cells associated with disease, iNKT and NKT-like cells with current smoking
por: Eriksson Ström, Jonas, et al.
Publicado: (2018)

CD1d expression in glioblastoma is a promising target for NKT cell-based cancer immunotherapy
por: Hara, Ayaka, et al.
Publicado: (2020)

miR-150 regulates the development of NK and iNKT cells
por: Bezman, Natalie A., et al.
Publicado: (2011)

NK and NKT Cell-Mediated Immune Surveillance against Hematological Malignancies
por: Shimizu, Kanako, et al.
Publicado: (2020)

Dendritic Cell-Based Immunotherapy Treatment for Glioblastoma Multiforme
por: Yang, Liu, et al.
Publicado: (2015)

The Advantages and Challenges of Anticancer Dendritic Cell Vaccines and NK Cells in Adoptive Cell Immunotherapy
por: Abakushina, Elena V., et al.
Publicado: (2021)

The Current Landscape of NKT Cell Immunotherapy and the Hills Ahead
por: Nelson, Adam, et al.
Publicado: (2021)

Augmentation of NKT and NK cell-mediated cytotoxicity by peptidoglycan monomer linked with zinc.
por: Mrakovcić-Sutić, Ines, et al.
Publicado: (2002)

Differential inhibitory and activating NK cell receptor levels and NK/NKT-like cell functionality in chronic and recovered stages of chikungunya
por: Thanapati, Subrat, et al.
Publicado: (2017)

Targeting the dendritic cell-T cell axis to develop effective immunotherapies for glioblastoma
por: Gardam, Bryan, et al.
Publicado: (2023)

Key features and homing properties of NK cells in the liver are shaped by activated iNKT cells
por: Trittel, Stephanie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_guiie5q0u1b5e2s2khec1071kc